title: Serum level of interleukin-4 is a possible marker of therapeutic response to interferon treatment in patients with chronic hepatitis C.
authors.forename: N
authors.initials: N
authors.lastname: Higashi
authors.forename: M
authors.initials: M
authors.lastname: Nakamuta
authors.forename: K
authors.initials: K
authors.lastname: Motomura
authors.forename: M
authors.initials: M
authors.lastname: Enjoji
authors.forename: H
authors.initials: H
authors.lastname: Sakai
authors.forename: H
authors.initials: H
authors.lastname: Nawata
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood*; D016207:Cytokines / Q000097:blood; D016174:Hepacivirus / Q000187:drug effects / Q000472:pathogenicity; D019698:Hepatitis C, Chronic / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D015847:Interleukin-4 / Q000097:blood*
chemical_list: D000998:Antiviral Agents; D015415:Biomarkers; D016207:Cytokines; D016898:Interferon-alpha; D015847:Interleukin-4